Bicarbonate for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501304-10-00

Enrollment

778

Registered

2022-09-26

Start date

2023-02-06

Completion date

Unknown

Last updated

2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In-hospital cardiac arrest

Brief summary

Return of spontaneous circulation

Detailed description

Survival at 30 days, Survival at 30 days with a favorable neurological outcome (modified Rankin Scale score 0 - 3)

Interventions

DRUGNatriumbikarbonat ”SAD”

DRUGkoncentrat til infusionsvæske

DRUGopløsning

DRUGNatriumklorid isotonisk "SAD"

DRUGinjektionsvæske

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Return of spontaneous circulation	—

Secondary

Measure	Time frame
Survival at 30 days, Survival at 30 days with a favorable neurological outcome (modified Rankin Scale score 0 - 3)	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026